BrainsWay Ltd.
BrainsWay Ltd; Department of Life Sciences, Ben Gurion University of the Negev, Israel.
Psychiatr Clin North Am. 2023 Mar;46(1):133-166. doi: 10.1016/j.psc.2022.10.003. Epub 2022 Dec 26.
Obsessive-compulsive disorder (OCD) patients need novel therapeutic interventions since most experience residual symptoms despite treatment. Converging evidence suggest that OCD involves dysfunction of limbic cortico-striato-thalamo-cortical loops, including the medial prefrontal cortex (mPFC) and dorsal anterior cingulate cortex (dACC), that tends to normalize with successful treatment. Recently, three repetitive transcranial magnetic stimulation (rTMS) coils were FDA-cleared for treatment-refractory OCD. This review presents on-label and off-label clinical evidence and relevant physical characteristics of the three coils. The Deep TMS™ H7 Coil studies' point to efficacy of mPFC-dACC stimulation, while no clear target stems from the small heterogenous D-B80 and figure-8 coils studies.
强迫症(OCD)患者需要新的治疗干预措施,因为大多数患者尽管接受了治疗,但仍存在残留症状。越来越多的证据表明,强迫症涉及边缘皮质纹状体丘脑皮质回路的功能障碍,包括内侧前额叶皮质(mPFC)和背侧前扣带皮质(dACC),这些回路在成功治疗后往往会恢复正常。最近,三种重复经颅磁刺激(rTMS)线圈已获得 FDA 批准用于治疗难治性 OCD。本综述介绍了三种线圈的标签内和标签外临床证据和相关物理特征。Deep TMS™ H7 线圈研究表明 mPFC-dACC 刺激的疗效,而 D-B80 和 figure-8 线圈的小异质性研究则没有明确的靶点。